Genetic and microbial regulation of NOD2 signaling in homeostasis and disease

Abstract

Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is a key intracellular pattern recognition receptor that senses bacterial peptidoglycan-conserved motifs, and has long been implicated in initiating immune responses. Loss-of-function mutations in NOD2 have been identified as the strongest genetic risk factor for Crohn’s disease (CD), a primary subtype of inflammatory bowel disease (IBD), underscoring its significance in the gut homeostasis. Recent advancements extend our understanding of NOD2, revealing how gut microbiota variation impacts NOD2 signaling and broadening its pathological significance far beyond CD. This review highlights the transition from focusing on genetic mutations in NOD2 to examining its dynamic regulation by the gut microbiome. This new perspective not only deepens our understanding of NOD2 in diverse health contexts, but also paves the way for innovative therapeutic strategies targeting the gut microbiota–NOD2 axis.

Keywords

gut microbiota / NOD2 / immune / gut barrier / probiotics

References

[1] Caruso R , Warner N , Inohara N , Nunez G . NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 2014; 41(6): 898–908

[2] Li Z , Shang D . NOD1 and NOD2: essential monitoring partners in the innate immune system. Curr Issues Mol Biol 2024; 46(9): 9463–9479

[3] Ashton JJ , Seaby EG , Beattie RM , Ennis S . NOD2 in Crohn’s disease—unfinished business. J Crohns Colitis 2023; 17(3): 450–458

[4] Ogura Y , Bonen DK , Inohara N , Nicolae DL , Chen FF , Ramos R , Britton H , Moran T , Karaliuskas R , Duerr RH , Achkar JP , Brant SR , Bayless TM , Kirschner BS , Hanauer SB , Nuñez G , Cho JH . A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001; 411(6837): 603–606

[5] Kayali S , Fantasia S , Gaiani F , Cavallaro LG , de’Angelis GL , Laghi L . NOD2 and Crohn’s disease clinical practice: from epidemiology to diagnosis and therapy, rewired. Inflamm Bowel Dis 2025; 31(2): 552–562

[6] Zhang Q , Wang X , Zheng J , Lü Q , Li R , Jia X , Gu M . Heterozygous variants of NOD2, IL10RA, PLA2G6 and COL7A1 correlate with Crohn’s disease. Heliyon 2024; 10(1): e22968

[7] Caruso R , Lo BC , Chen GY , Núñez G . Host–pathobiont interactions in Crohn’s disease. Nat Rev Gastroenterol Hepatol 2025; 22(6): 395–414

[8] Dolinger M , Torres J , Vermeire S . Crohn’s disease. Lancet 2024; 403(10432): 1177–1191

[9] Gao J , Zhao X , Hu S , Huang Z , Hu M , Jin S , Lu B , Sun K , Wang Z , Fu J , Weersma RK , He X , Zhou H. . Gut microbial DL-endopeptidase alleviates Crohn’s disease via the NOD2 pathway.. Cell Host Microbe 2022; 30(10): e9–1449

[10] Klupt S , Fam KT , Zhang X , Chodisetti PK , Mehmood A , Boyd T , Grotjahn D , Park D , Hang HC . Secreted antigen A peptidoglycan hydrolase is essential for Enterococcus faecium cell separation and priming of immune checkpoint inhibitor therapy. Elife 2024; 13: RP95297

[11] Wheeler R , Boneca IG . The hidden base of the iceberg: gut peptidoglycome dynamics is foundational to its influence on the host. Gut Microbes 2024; 16(1): 2395099

[12] Griffin ME , Klupt S , Espinosa J , Hang HC . Peptidoglycan NlpC/P60 peptidases in bacterial physiology and host interactions. Cell Chem Biol 2023; 30(5): 436–456

[13] Qiu M , Ye C , Bao L , Wu K , Zhao Y , Zhao X , Tang R , Shang R , Shang S , Yuan C , Hu X , Zhang N , Fu Y , Wang J , Zhao C . Elevated muramyl dipeptide by sialic acid-facilitated postantibiotic pathobiont expansion contributes to gut dysbiosis-induced mastitis in mice. J Adv Res 2025; 74: 667–680

[14] He X , Zhou H . Decoding the IBD paradox: a triadic interplay between REG3, enterococci, and NOD2. Cell Host Microbe 2023; 31(9): 1425–1427

[15] Ogura Y , Inohara N , Benito A , Chen FF , Yamaoka S , Nunez G . Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem 2001; 276(7): 4812–4818

[16] Kufer TA , Kremmer E , Banks DJ , Philpott DJ . Role for Erbin in bacterial activation of Nod2. Infect Immun 2006; 74(6): 3115–3124

[17] Rosenstiel P , Hellmig S , Hampe J , Ott S , Till A , Fischbach W , Sahly H , Lucius R , Fölsch UR , Philpott D , Schreiber S . Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 2006; 8(7): 1188–1198

[18] Fritz JH , Ferrero RL , Philpott DJ , Girardin SE . Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006; 7(12): 1250–1257

[19] Mehto S , Jena KK , Yadav R , Priyadarsini S , Samal P , Krishna S , Dhar K , Jain A , Chauhan NR , Murmu KC , Bal R , Sahu R , Jaiswal P , Sahoo BS , Patnaik S , Kufer TA , Rusten TE , Chauhan S , Prasad P , Chauhan S . Selective autophagy of RIPosomes maintains innate immune homeostasis during bacterial infection. EMBO J 2022; 41(23): e111289

[20] Bist P , Dikshit N , Koh TH , Mortellaro A , Tan TT , Sukumaran B . The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection. Infect Immun 2014; 82(3): 1112–1122

[21] Vissers M , Remijn T , Oosting M , de Jong DJ , Diavatopoulos DA , Hermans PW , Ferwerda G . Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells. Eur J Immunol 2012; 42(10): 2727–2735

[22] Deshmukh HS , Hamburger JB , Ahn SH , McCafferty DG , Yang SR , Fowler VG Jr . Critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infect Immun 2009; 77(4): 1376–1382

[23] Franchi L , Park JH , Shaw MH , Marina-Garcia N , Chen G , Kim YG , Núñez G . Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol 2008; 10(1): 1–8

[24] Yang Y , Yin C , Pandey A , Abbott D , Sassetti C , Kelliher MA . NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J Biol Chem 2007; 282(50): 36223–36229

[25] Akira S , Uematsu S , Takeuchi O . Pathogen recognition and innate immunity. Cell 2006; 124(4): 783–801

[26] Du X , Alam M , Witek K , Milnes L , Houghton J , Lin X , Ahn HK , Zhang Y , Cui F , Sun W , Jones JDG , Guo H. . Interfamily co-transfer of sensor and helper NLRs extends immune receptor functionality between angiosperms.. Cell 2025; 188(17): 4505–4516

[27] Zou G , Tang Y , Yang J , Fu S , Li Y , Ren X , Zhou N , Zhao W , Gao J , Ruan Z , Jiang Z . Signal-induced NLRP3 phase separation initiates inflammasome activation. Cell Res 2025; 35(6): 437–452

[28] Lu P , Zhang G , Li J , Gong Z , Wang G , Dong L , Zhang H , Guo G , Su M , Wang K , Wang Y , Zhu K , Wu Q , Chen Y , Li M , Huang B , Li B , Li W , Dong L , Hou Y , Cui X , Fu H , Qiu D , Yuan C , Li H , Zhou JM , Han GZ , Chen Y , Liu Z . A wheat tandem kinase and NLR pair confers resistance to multiple fungal pathogens. Science 2025; 387(6741): 1418–1424

[29] Liu F , Yang Z , Wang C , You Z , Martin R , Qiao W , Huang J , Jacob P , Dangl JL , Carette JE , Luan S , Nogales E , Staskawicz BJ. . Activation of the helper NRC4 immune receptor forms a hexameric resistosome.. Cell 2024; 187(18): e15–4889

[30] Sundaram B , Tweedell RE , Prasanth Kumar S , Kanneganti TD . The NLR family of innate immune and cell death sensors. Immunity 2024; 57(4): 674–699

[31] Chou WC , Jha S , Linhoff MW , Ting JP . The NLR gene family: from discovery to present day. Nat Rev Immunol 2023; 23(10): 635–654

[32] Trindade BC , Chen GY . NOD1 and NOD2 in inflammatory and infectious diseases. Immunol Rev 2020; 297(1): 139–161

[33] Grimes CL , De Zoysa Ariyananda L , Melnyk JE , O’Shea EK . The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment. J Am Chem Soc 2012; 134(33): 13535–13537

[34] Warner N , Burberry A , Franchi L , Kim YG , McDonald C , Sartor MA , Núñez G . A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways. Sci Signal 2013; 6(258): rs3

[35] Nakamura N , Lill JR , Phung Q , Jiang Z , Bakalarski C , de Maziere A , Klumperman J , Schlatter M , Delamarre L , Mellman I . Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 2014; 509(7499): 240–244

[36] Barnich N , Aguirre JE , Reinecker HC , Xavier R , Podolsky DK . Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-κB activation in muramyl dipeptide recognition. J Cell Biol 2005; 170(1): 21–26

[37] Dixon CL , Fairn GD . S-palmitoylation of NOD2 controls its localization to the plasma membrane. J Lipid Res 2021; 62: 100097

[38] Mohanan V , Grimes CL . The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease. J Biol Chem 2014; 289(27): 18987–18998

[39] Ogura Y , Lala S , Xin W , Smith E , Dowds TA , Chen FF , Zimmermann E , Tretiakova M , Cho JH , Hart J , Greenson JK , Keshav S , Nuñez G . Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis. Gut 2003; 52(11): 1591–1597

[40] Parkhouse R , Boyle JP , Monie TP . Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators. FEBS Lett 2014; 588(18): 3382–3389

[41] Lu Y , Zheng Y , Coyaud E , Zhang C , Selvabaskaran A , Yu Y , Xu Z , Weng X , Chen JS , Meng Y , Warner N , Cheng X , Liu Y , Yao B , Hu H , Xia Z , Muise AM , Klip A , Brumell JH , Girardin SE , Ying S , Fairn GD , Raught B , Sun Q , Neculai D . Palmitoylation of NOD1 and NOD2 is required for bacterial sensing. Science 2019; 366(6464): 460–467

[42] Zhou L , He X , Wang L , Wei P , Cai Z , Zhang S , Jin S , Zeng H , Cui J . Palmitoylation restricts SQSTM1/p62-mediated autophagic degradation of NOD2 to modulate inflammation. Cell Death Differ 2022; 29(8): 1541–1551

[43] Charrière GM , Ip WE , Dejardin S , Boyer L , Sokolovska A , Cappillino MP , Cherayil BJ , Podolsky DK , Kobayashi KS , Silverman N , Lacy-Hulbert A , Stuart LM . Identification of Drosophila Yin and PEPT2 as evolutionarily conserved phagosome-associated muramyl dipeptide transporters. J Biol Chem 2010; 285(26): 20147–20154

[44] Lauro ML , D’Ambrosio EA , Bahnson BJ , Grimes CL . Molecular recognition of muramyl dipeptide occurs in the leucine-rich repeat domain of Nod2. ACS Infect Dis 2017; 3(4): 264–270

[45] Stafford CA , Gassauer AM , de Oliveira Mann CC , Tanzer MC , Fessler E , Wefers B , Nagl D , Kuut G , Sulek K , Vasilopoulou C , Schwojer SJ , Wiest A , Pfautsch MK , Wurst W , Yabal M , Fröhlich T , Mann M , Gisch N , Jae LT , Hornung V . Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation. Nature 2022; 609(7927): 590–596

[46] Sabbah A , Chang TH , Harnack R , Frohlich V , Tominaga K , Dube PH , Xiang Y , Bose S . Activation of innate immune antiviral responses by Nod2. Nat Immunol 2009; 10(10): 1073–1080

[47] Keestra-Gounder AM , Byndloss MX , Seyffert N , Young BM , Chávez-Arroyo A , Tsai AY , Cevallos SA , Winter MG , Pham OH , Tiffany CR , de Jong MF , Kerrinnes T , Ravindran R , Luciw PA , McSorley SJ , Bäumler AJ , Tsolis RM . NOD1 and NOD2 signalling links ER stress with inflammation. Nature 2016; 532(7599): 394–397

[48] Pei G , Zyla J , He L , Moura-Alves P , Steinle H , Saikali P , Lozza L , Nieuwenhuizen N , Weiner J , Mollenkopf HJ , Ellwanger K , Arnold C , Duan M , Dagil Y , Pashenkov M , Boneca IG , Kufer TA , Dorhoi A , Kaufmann SHE . Cellular stress promotes NOD1/2-dependent inflammation via the endogenous metabolite sphingosine-1-phosphate. EMBO J 2021; 40(13): e106272

[49] Albrecht M , Domingues FS , Schreiber S , Lengauer T . Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett 2003; 554(3): 520–528

[50] Inohara N , Chamaillard M , McDonald C , Nuñez G . NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005; 74(1): 355–383

[51] Macaluso F , Nothnagel M , Parwez Q , Petrasch-Parwez E , Bechara FG , Epplen JT , Hoffjan S . Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis. Exp Dermatol 2007; 16(8): 692–698

[52] Joosten LA , Heinhuis B , Abdollahi-Roodsaz S , Ferwerda G , Lebourhis L , Philpott DJ , Nahori MA , Popa C , Morre SA , van der Meer JW , Girardin SE , Netea MG , van den Berg WB . Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis. Proc Natl Acad Sci USA 2008; 105(26): 9017–9022

[53] Vijayrajratnam S , Pushkaran AC , Balakrishnan A , Vasudevan AK , Biswas R , Mohan CG . Understanding the molecular differential recognition of muramyl peptide ligands by LRR domains of human NOD receptors. Biochem J 2017; 474(16): 2691–2711

[54] Alipoor SD , Mirsaeidi M . Inborn errors in the LRR domain of Nod2 and their potential consequences on the function of the receptor. Cells 2021; 10(8): 2031

[55] Yan J , Hedl M , Abraham C . An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes. J Clin Invest 2017; 127(6): 2192–2205

[56] Fiil BK , Damgaard RB , Wagner SA , Keusekotten K , Fritsch M , Bekker-Jensen S , Mailand N , Choudhary C , Komander D , Gyrd-Hansen M . OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol Cell 2013; 50(6): 818–830

[57] Zhao Y , Alonso C , Ballester I , Song JH , Chang SY , Guleng B , Arihiro S , Murray PJ , Xavier R , Kobayashi KS , Reinecker HC . Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Inflamm Bowel Dis 2012; 18(4): 603–612

[58] Philpott DJ , Sorbara MT , Robertson SJ , Croitoru K , Girardin SE . NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 2014; 14(1): 9–23

[59] Watanabe T , Asano N , Meng G , Yamashita K , Arai Y , Sakurai T , Kudo M , Fuss IJ , Kitani A , Shimosegawa T , Chiba T , Strober W . NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6. Mucosal Immunol 2014; 7(6): 1312–1325

[60] Tao M , Scacheri PC , Marinis JM , Harhaj EW , Matesic LE , Abbott DW . ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr Biol 2009; 19(15): 1255–1263

[61] Abbott DW , Yang Y , Hutti JE , Madhavarapu S , Kelliher MA , Cantley LC . Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol Cell Biol 2007; 27(17): 6012–6025

[62] Hasegawa M , Fujimoto Y , Lucas PC , Nakano H , Fukase K , Nunez G , Inohara N . A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-κB activation. EMBO J 2008; 27(2): 373–383

[63] Tokunaga F , Sakata S , Saeki Y , Satomi Y , Kirisako T , Kamei K , Nakagawa T , Kato M , Murata S , Yamaoka S , Yamamoto M , Akira S , Takao T , Tanaka K , Iwai K . Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat Cell Biol 2009; 11(2): 123–132

[64] Wang C , Deng L , Hong M , Akkaraju GR , Inoue J , Chen ZJ . TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412(6844): 346–351

[65] Chen CM , Gong Y , Zhang M , Chen JJ . Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J Biol Chem 2004; 279(24): 25876–25882

[66] Kim JY , Omori E , Matsumoto K , Núñez G , Ninomiya-Tsuji J . TAK1 is a central mediator of NOD2 signaling in epidermal cells. J Biol Chem 2008; 283(1): 137–144

[67] Liang J , Zeng X , Halifu Y , Chen W , Hu F , Wang P , Zhang H , Kang X . Blocking RhoA/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1/NOD2-mediated NF-κB pathway. Mol Cell Biochem 2017; 436(1-2): 151–158

[68] Li J , Moran T , Swanson E , Julian C , Harris J , Bonen DK , Hedl M , Nicolae DL , Abraham C , Cho JH . Regulation of IL-8 and IL-1β expression in Crohn’s disease associated NOD2/CARD15 mutations. Hum Mol Genet 2004; 13(16): 1715–1725

[69] Chamaillard M , Philpott D , Girardin SE , Zouali H , Lesage S , Chareyre F , Bui TH , Giovannini M , Zaehringer U , Penard-Lacronique V , Sansonetti PJ , Hugot JP , Thomas G . Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003; 100(6): 3455–3460

[70] Zhou B , Yin M , Su X , Sheng S , Du X , Shen J , Chen K , Wang D , Zhu Z , Xu Y , Li Z , Li J , Li Y , Ruan J , Wang X . DUBA sustains the stability of NOD2 and RIPK2 to enhance innate immune responses. Cell Death Differ 2025; 32(11): 2053–2065

[71] Jiang W , Zhao Y , Han M , Xu J , Chen K , Liang Y , Yin J , Hu J , Shen Y . N4BP3 facilitates NOD2-MAPK/NF-κB pathway in inflammatory bowel disease through mediating K63-linked RIPK2 ubiquitination. Cell Death Discov 2024; 10(1): 440

[72] Muharram G , Thépaut M , Lobert PE , Grandjean T , Boulard O , Delacre M , Wakeford E , Wheeler R , Poulin LF , Boneca IG , Lafont F , Michallet MC , Hober D , Cadwell K , Chamaillard M . Activation of Nod2 signaling upon norovirus infection enhances antiviral immunity and susceptibility to colitis. Gut Microbes 2023; 15(2): 2249960

[73] Rosenstiel P , Fantini M , Bräutigam K , Kühbacher T , Waetzig GH , Seegert D , Schreiber S . TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124(4): 1001–1009

[74] Rosenzweig HL , Kawaguchi T , Martin TM , Planck SR , Davey MP , Rosenbaum JT . Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma. Invest Ophthalmol Vis Sci 2009; 50(4): 1739–1745

[75] Parackova Z , Bloomfield M , Vrabcova P , Zentsova I , Klocperk A , Milota T , Svaton M , Casanova JL , Bustamante J , Fronkova E , Sediva A . Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency. J Clin Immunol 2020; 40(1): 165–178

[76] Boada-Romero E , Letek M , Fleischer A , Pallauf K , Ramón-Barros C , Pimentel-Muiños FX . TMEM59 defines a novel ATG16L1-binding motif that promotes local activation of LC3. EMBO J 2013; 32(4): 566–582

[77] Prescott NJ , Fisher SA , Franke A , Hampe J , Onnie CM , Soars D , Bagnall R , Mirza MM , Sanderson J , Forbes A , Mansfield JC , Lewis CM , Schreiber S , Mathew CG . A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn’s disease and is independent of CARD15 and IBD5. Gastroenterology 2007; 132(5): 1665–1671

[78] Okazaki T , Wang MH , Rawsthorne P , Sargent M , Datta LW , Shugart YY , Bernstein CN , Brant SR . Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn’s disease risk in a population-based case-control study: evidence of gene–gene interactions. Inflamm Bowel Dis 2008; 14(11): 1528–1541

[79] Homer CR , Richmond AL , Rebert NA , Achkar JP , McDonald C. . ATG16L1 and NOD2 interact in an autophagy-dependent, anti-bacterial pathway implicated in Crohn’s disease pathogenesis.. Gastroenterology 2010; 139(5): e2–1641

[80] Glubb DM , Gearry RB , Barclay ML , Roberts RL , Pearson J , Keenan JI , McKenzie J , Bentley RW . NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn’s disease. World J Gastroenterol 2011; 17(23): 2829–2837

[81] Hu J , Peter I . Evidence of expression variation and allelic imbalance in Crohn’s disease susceptibility genes NOD2 and ATG16L1 in human dendritic cells. Gene 2013; 527(2): 496–502

[82] Travassos LH , Carneiro LA , Ramjeet M , Hussey S , Kim YG , Magalhaes JG , Yuan L , Soares F , Chea E , Le Bourhis L , Boneca IG , Allaoui A , Jones NL , Nunez G , Girardin SE , Philpott DJ . Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11(1): 55–62

[83] Hampe J , Frenzel H , Mirza MM , Croucher PJ , Cuthbert A , Mascheretti S , Huse K , Platzer M , Bridger S , Meyer B , Nürnberg P , Stokkers P , Krawczak M , Mathew CG , Curran M , Schreiber S . Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci USA 2002; 99(1): 321–326

[84] Zhou Z , Lin XY , Akolkar PN , Gulwani-Akolkar B , Levine J , Katz S , Silver J . Variation at NOD2/CARD15 in familial and sporadic cases of Crohn’s disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002; 97(12): 3095–3101

[85] Hampe J , Grebe J , Nikolaus S , Solberg C , Croucher PJ , Mascheretti S , Jahnsen J , Moum B , Klump B , Krawczak M , Mirza MM , Foelsch UR , Vatn M , Schreiber S . Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. Lancet 2002; 359(9318): 1661–1665

[86] Cuthbert AP , Fisher SA , Mirza MM , King K , Hampe J , Croucher PJ , Mascheretti S , Sanderson J , Forbes A , Mansfield J , Schreiber S , Lewis CM , Mathew CG . The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122(4): 867–874

[87] Vermeire S , Wild G , Kocher K , Cousineau J , Dufresne L , Bitton A , Langelier D , Pare P , Lapointe G , Cohen A , Daly MJ , Rioux JD . CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71(1): 74–83

[88] Hampe J , Cuthbert A , Croucher PJ , Mirza MM , Mascheretti S , Fisher S , Frenzel H , King K , Hasselmeyer A , MacPherson AJ , Bridger S , van Deventer S , Forbes A , Nikolaus S , Lennard-Jones JE , Foelsch UR , Krawczak M , Lewis C , Schreiber S , Mathew CG . Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 2001; 357(9272): 1925–1928

[89] Hugot JP , Chamaillard M , Zouali H , Lesage S , Cézard JP , Belaiche J , Almer S , Tysk C , O’Morain CA , Gassull M , Binder V , Finkel Y , Cortot A , Modigliani R , Laurent-Puig P , Gower-Rousseau C , Macry J , Colombel JF , Sahbatou M , Thomas G . Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001; 411(6837): 599–603

[90] Tüzün İnce A , Hatırnaz Ö , Övünç O , Özbek U . 1007fs, G908R, R702W mutations and P268S, IVS8⁺¹⁵⁸ polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery. Dig Dis Sci 2008; 53(6): 1683–1692

[91] Zaahl MG , Winter T , Warnich L , Kotze MJ . Analysis of the three common mutations in the CARD15 gene (R702W, G908R, and 1007fs) in South African colored patients with inflammatory bowel disease. Mol Cell Probes 2005; 19(4): 278–281

[92] Inohara N , Nunez G . NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003; 3(5): 371–382

[93] Abreu MT , Taylor KD , Lin YC , Hang T , Gaiennie J , Landers CJ , Vasiliauskas EA , Kam LY , Rojany M , Papadakis KA , Rotter JI , Targan SR , Yang H . Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease. Gastroenterology 2002; 123(3): 679–688

[94] Behnisch S , Reiner J , Witte M , Holle A , Schäffler H , Huth A , Jaster R , Lamprecht G . P907 NOD2 mutations are associated with the development of inflammatory and progressive digestive tract damage in Crohn’s disease. J Crohns Colitis 2023; 17(Suppl1): i1019–i1020

[95] Pernat Drobež C , Ferkolj I , Potočnik U , Repnik K . Crohn’s disease candidate gene alleles predict time to progression from inflammatory B1 to stricturing B2, or penetrating B3 phenotype. Genet Test Mol Biomarkers 2018; 22(3): 143–151

[96] Alvarez-Lobos M , Arostegui JI , Sans M , Tassies D , Plaza S , Delgado S , Lacy AM , Pique JM , Yagüe J , Panés J . Crohn’s disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 2005; 242(5): 693–700

[97] Noguchi E , Homma Y , Kang X , Netea MG , Ma X . A Crohn’s disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol 2009; 10(5): 471–479

[98] Sorbara MT , Ellison LK , Ramjeet M , Travassos LH , Jones NL , Girardin SE , Philpott DJ . The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner. Immunity 2013; 39(5): 858–873

[99] Rocha JD , Schlossmacher MG , Philpott DJ . LRRK2 and Nod2 promote lysozyme sorting in Paneth cells. Nat Immunol 2015; 16(9): 898–900

[100] Guo QS , Xia B , Jiang Y , Qu Y , Li J . NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol 2004; 10(7): 1069–1071

[101] Li M , Gao X , Guo CC , Wu KC , Zhang X , Hu PJ . OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2008; 14(31): 4923–4927

[102] Long WY , Chen L , Zhang CL , Nong RM , Lin MJ , Zhan LL , Lv XP . Association between NOD2/CARD15 gene polymorphisms and Crohn’s disease in Chinese Zhuang patients. World J Gastroenterol 2014; 20(16): 4737–4744

[103] Xiong JH , Mao C , Sha XW , Jin Z , Wang H , Liu YY , Ning Y . Association between genetic variants in NOD2, C13orf31, and CCDC122 genes and leprosy among the Chinese Yi population. Int J Dermatol 2016; 55(1): 65–69

[104] Inoue N , Tamura K , Kinouchi Y , Fukuda Y , Takahashi S , Ogura Y , Inohara N , Núñez G , Kishi Y , Koike Y , Shimosegawa T , Shimoyama T , Hibi T . Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology 2002; 123(1): 86–91

[105] Sugimura M , Kinouchi Y , Takahashi S , Aihara H , Takagi S , Negoro K , Obana N , Kojima Y , Matsumoto K , Kikuchi T , Hiroki M , Oomori S , Shimosegawa T . CARD15/NOD2 mutational analysis in Japanese patients with Crohn’s disease. Clin Genet 2003; 63(2): 160–162

[106] Jang JY , Song SM , Kim KM , Oh SH , Lee YJ , Rhee KW . Lack of common NOD2 mutations in Korean pediatric patients with inflammatory bowel disease. Pediatr Int 2010; 52(6): 888–889

[107] Leong RW , Armuzzi A , Ahmad T , Wong ML , Tse P , Jewell DP , Sung JJ . NOD2/CARD15 gene polymorphisms and Crohn’s disease in the Chinese population. Aliment Pharmacol Ther 2003; 17(12): 1465–1470

[108] Yamazaki K , Takazoe M , Tanaka T , Kazumori T , Nakamura Y . Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn’s disease. J Hum Genet 2002; 47(9): 469–472

[109] Lesage S , Zouali H , Cézard JP , Colombel JF , Belaiche J , Almer S , Tysk C , O’Morain C , Gassull M , Binder V , Finkel Y , Modigliani R , Gower-Rousseau C , Macry J , Merlin F , Chamaillard M , Jannot AS , Thomas G , Hugot JP . CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70(4): 845–857

[110] Bonen DK , Ogura Y , Nicolae DL , Inohara N , Saab L , Tanabe T , Chen FF , Foster SJ , Duerr RH , Brant SR , Cho JH , Nuñez G . Crohn’s disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003; 124(1): 140–146

[111] van Heel DA , Ghosh S , Butler M , Hunt KA , Lundberg AM , Ahmad T , McGovern DP , Onnie C , Negoro K , Goldthorpe S , Foxwell BM , Mathew CG , Forbes A , Jewell DP , Playford RJ . Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn’s disease. Lancet 2005; 365(9473): 1794–1796

[112] Lécline P , Esmiol S , Métais JY , Nicoletti C , Nourry C , McDonald C , Nunez G , Hugot JP , Borg JP , Ollendorff V . The NOD2-RICK complex signals from the plasma membrane. J Biol Chem 2007; 282: 15197–15207

[113] Wehkamp J , Harder J , Weichenthal M , Schwab M , Schaffeler E , Schlee M , Herrlinger KR , Stallmach A , Noack F , Fritz P , Schröder JM , Bevins CL , Fellermann K , Stange EF . NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53(11): 1658–1664

[114] Knights D , Silverberg MS , Weersma RK , Gevers D , Dijkstra G , Huang H , Tyler AD , van Sommeren S , Imhann F , Stempak JM , Huang H , Vangay P , Al-Ghalith GA , Russell C , Sauk J , Knight J , Daly MJ , Huttenhower C , Xavier RJ . Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med 2014; 6(12): 107

[115] Rochereau N , Roblin X , Michaud E , Gayet R , Chanut B , Jospin F , Corthesy B , Paul S . NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn’s disease. Nat Commun 2021; 12(1): 261

[116] Maeda S , Hsu LC , Liu H , Bankston LA , Iimura M , Kagnoff MF , Eckmann L , Karin M . Nod2 mutation in Crohn’s disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307(5710): 734–738

[117] Negroni A , Pierdomenico M , Cucchiara S , Stronati L . NOD2 and inflammation: current insights. J Inflamm Res 2018; 11: 49–60

[118] Hardman CS , Chen YL , Salimi M , Nahler J , Corridoni D , Jagielowicz M , Fonseka CL , Johnson D , Repapi E , Cousins DJ , Barlow JL , McKenzie ANJ , Simmons A , Ogg G . IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent. Sci Immunol 2021; 6(59): eabe5084

[119] Ekman AK , Cardell LO . The expression and function of Nod-like receptors in neutrophils. Immunology 2010; 130(1): 55–63

[120] Wolfkamp SC , Verseyden C , Vogels EW , Meisner S , Boonstra K , Peters CP , Stokkers PC , te Velde AA . ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn’s disease patients. World J Gastroenterol 2014; 20(10): 2664–2672

[121] Lessard AJ , LeBel M , Egarnes B , Préfontaine P , Thériault P , Droit A , Brunet A , Rivest S , Gosselin J . Triggering of NOD2 receptor converts inflammatory Ly6C^high into Ly6C^low monocytes with patrolling properties. Cell Rep 2017; 20(8): 1830–1843

[122] Normand S , Waldschmitt N , Neerincx A , Martinez-Torres RJ , Chauvin C , Couturier-Maillard A , Boulard O , Cobret L , Awad F , Huot L , Ribeiro-Ribeiro A , Lautz K , Ruez R , Delacre M , Bondu C , Guilliams M , Scott C , Segal A , Amselem S , Hot D , Karabina S , Bohn E , Ryffel B , Poulin LF , Kufer TA , Chamaillard M . Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens. Nat Commun 2018; 9(1): 5338

[123] Beynon V , Cotofana S , Brand S , Lohse P , Mair A , Wagner S , Mussack T , Ochsenkühn T , Folwaczny M , Folwaczny C , Glas J , Török HP . NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes. Inflamm Bowel Dis 2008; 14(8): 1033–1040

[124] Fritz JH , Girardin SE , Fitting C , Werts C , Mengin-Lecreulx D , Caroff M , Cavaillon JM , Philpott DJ , Adib-Conquy M . Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol 2005; 35(8): 2459–2470

[125] van Beelen AJ , Zelinkova Z , Taanman-Kueter EW , Muller FJ , Hommes DW , Zaat SA , Kapsenberg ML , de Jong EC . Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007; 27(4): 660–669

[126] Butler M , Chaudhary R , van Heel DA , Playford RJ , Ghosh S . NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes—possible implications for NOD2-associated Crohn’s disease. J Crohns Colitis 2007; 1(2): 106–115

[127] Alnabhani Z , Hugot JP , Montcuquet N , Le Roux K , Dussaillant M , Roy M , Leclerc M , Cerf-Bensussan N , Lepage P , Barreau F . Respective roles of hematopoietic and nonhematopoietic Nod2 on the gut microbiota and mucosal homeostasis. Inflamm Bowel Dis 2016; 22(4): 763–773

[128] Al Nabhani Z , Montcuquet N , Roy M , Dussaillant M , Hugot JP , Barreau F . Complementary roles of Nod2 in hematopoietic and nonhematopoietic cells in preventing gut barrier dysfunction dependent on MLCK activity. Inflamm Bowel Dis 2017; 23(7): 1109–1119

[129] Couturier-Maillard A , Secher T , Rehman A , Normand S , De Arcangelis A , Haesler R , Huot L , Grandjean T , Bressenot A , Delanoye-Crespin A , Gaillot O , Schreiber S , Lemoine Y , Ryffel B , Hot D , Nùñez G , Chen G , Rosenstiel P , Chamaillard M . NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 2013; 123(2): 700–711

[130] Jang KK , Heaney T , London M , Ding Y , Putzel G , Yeung F , Ercelen D , Chen YH , Axelrad J , Gurunathan S , Zhou C , Podkowik M , Arguelles N , Srivastava A , Shopsin B , Torres VJ , Keestra-Gounder AM , Pironti A , Griffin ME , Hang HC , Cadwell K. . Antimicrobial overproduction sustains intestinal inflammation by inhibiting Enterococcus colonization.. Cell Host Microbe 2023; 31(9): 1450–1468.e8

[131] Gao J , Wang L , Jiang J , Xu Q , Zeng N , Lu B , Yuan P , Sun K , Zhou H , He X . A probiotic bi-functional peptidoglycan hydrolase sheds NOD2 ligands to regulate gut homeostasis in female mice. Nat Commun 2023; 14(1): 3338

[132] Heidrich V , Valles-Colomer M , Segata N . Human microbiome acquisition and transmission. Nat Rev Microbiol 2025; 23(9): 568–584

[133] Joos R , Boucher K , Lavelle A , Arumugam M , Blaser MJ , Claesson MJ , Clarke G , Cotter PD , De Sordi L , Dominguez-Bello MG , Dutilh BE , Ehrlich SD , Ghosh TS , Hill C , Junot C , Lahti L , Lawley TD , Licht TR , Maguin E , Makhalanyane TP , Marchesi JR , Matthijnssens J , Raes J , Ravel J , Salonen A , Scanlan PD , Shkoporov A , Stanton C , Thiele I , Tolstoy I , Walter J , Yang B , Yutin N , Zhernakova A , Zwart H; Human Microbiome Action Consortium; Doré J , Ross RP . Examining the healthy human microbiome concept. Nat Rev Microbiol 2025; 23(3): 192–205

[134] Abdill RJ , Graham SP , Rubinetti V , Ahmadian M , Hicks P , Chetty A , McDonald D , Ferretti P , Gibbons E , Rossi M , Krishnan A , Albert FW , Greene CS , Davis S , Blekhman R. . Integration of 168 000 samples reveals global patterns of the human gut microbiome.. Cell 2025; 188(4): e17–1118

[135] Rajilić-Stojanović M , de Vos WM . The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 2014; 38(5): 996–1047

[136] Laman JD , ’t Hart BA , Power C , Dziarski R . Bacterial peptidoglycan as a driver of chronic brain inflammation. Trends Mol Med 2020; 26(7): 670–682

[137] Egan AJF , Errington J , Vollmer W . Regulation of peptidoglycan synthesis and remodelling. Nat Rev Microbiol 2020; 18(8): 446–460

[138] Layec S , Decaris B , Leblond-Bourget N . Diversity of Firmicutes peptidoglycan hydrolases and specificities of those involved in daughter cell separation. Res Microbiol 2008; 159(7-8): 507–515

[139] Yao Q , Zhou L , Cusumano P , Bose N , Piliang M , Jayakar B , Su LC , Shen B . A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis Res Ther 2011; 13(5): R148

[140] Miceli-Richard C , Lesage S , Rybojad M , Prieur AM , Manouvrier-Hanu S , Hafner R , Chamaillard M , Zouali H , Thomas G , Hugot JP . CARD15 mutations in Blau syndrome. Nat Genet 2001; 29(1): 19–20

[141] Schürmann M , Valentonyte R , Hampe J , Müller-Quernheim J , Schwinger E , Schreiber S . CARD15 gene mutations in sarcoidosis. Eur Respir J 2003; 22(5): 748–754

[142] Martel J , Chang SH , Ko YF , Hwang TL , Young JD , Ojcius DM . Gut barrier disruption and chronic disease. Trends Endocrinol Metab 2022; 33(4): 247–265

[143] Appenrodt B , Grunhage F , Gentemann MG , Thyssen L , Sauerbruch T , Lammert F . Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 2010; 51(4): 1327–1333

[144] Mayor NP , Shaw BE , Hughes DA , Maldonado-Torres H , Madrigal JA , Keshav S , Marsh SG . Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J Clin Oncol 2007; 25(27): 4262–4269

[145] Kayar Y , Dertli R , Konur S , Agin M , Baran B , Ormeci AC , Akyuz F , Demir K , Besisik F , Kaymakoglu S . The development of extraintestinal manifestation and related risk factors in Crohn’s patients. Ir J Med Sci 2021; 190(2): 597–604

[146] Li J , Wu S , Wang MR , Wang TT , Li BK , Zhu JM . Potential roles of nucleotide-binding oligomerization domain 2 in the pathogenesis of systemic lupus erythematosus. Rheumatol Int 2014; 34(10): 1339–1344

[147] Rodriguez-Nunez I , Caluag T , Kirby K , Rudick CN , Dziarski R , Gupta D . Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction. Sci Rep 2017; 7(1): 548

[148] Shiny A , Regin B , Balachandar V , Gokulakrishnan K , Mohan V , Babu S , Balasubramanyam M . Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes. Cytokine 2013; 64(2): 564–570

[149] Piec PA , Pons V , Prefontaine P , Rivest S . Muramyl dipeptide administration delays Alzheimer’s disease physiopathology via NOD2 receptors. Cells 2022; 11(14): 2241

[150] Gabanyi I , Lepousez G , Wheeler R , Vieites-Prado A , Nissant A , Chevalier G , Wagner S , Moigneau C , Dulauroy S , Hicham S , Polomack B , Verny F , Rosenstiel P , Renier N , Boneca IG , Eberl G , Lledo PM . Bacterial sensing via neuronal Nod2 regulates appetite and body temperature. Science 2022; 376(6590): eabj3986

[151] Cheng L , Chen L , Wei X , Wang Y , Ren Z , Zeng S , Zhang X , Wen H , Gao C , Liu H . NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson’s disease. J Neuroinflammation 2018; 15(1): 243

[152] Cao B , Chen Y , Zhou Q , Zhang L , Ou R , Wei Q , Wu Y , Shang HF . Functional variant rs3135500 in NOD2 increases the risk of multiple system atrophy in a Chinese population. Front Aging Neurosci 2018; 10: 150

[153] Cavallari JF , Pokrajac NT , Zlitni S , Foley KP , Henriksbo BD , Schertzer JD . NOD2 in hepatocytes engages a liver–gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice. Am J Physiol Endocrinol Metab 2020; 319(2): E305–E314

[154] Wang L , Hartmann P , Haimerl M , Bathena SP , Sjowall C , Almer S , Alnouti Y , Hofmann AF , Schnabl B . Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids. J Hepatol 2014; 60(6): 1259–1267

[155] Zhang S , Zhang S , Hu L , Zhai L , Xue R , Ye J , Chen L , Cheng G , Mruk J , Kunapuli SP , Ding Z . Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis. Circulation 2015; 131(13): 1160–1170

[156] Mulla MJ , Pasternak MC , Salmon JE , Chamley LW , Abrahams VM . Role of NOD2 in antiphospholipid antibody-induced and bacterial MDP amplification of trophoblast inflammation. J Autoimmun 2019; 98: 103–112

[157] Yuan H , Zelkha S , Burkatovskaya M , Gupte R , Leeman SE , Amar S . Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss. Proc Natl Acad Sci USA 2013; 110(52): E5059–E5068

[158] Kapetanovic R , Jouvion G , Fitting C , Parlato M , Blanchet C , Huerre M , Cavaillon JM , Adib-Conquy M . Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia. Microbes Infect 2010; 12(10): 759–767

[159] Wong CK , Hu S , Leung KM , Dong J , He L , Chu YJ , Chu IM , Qiu HN , Liu KY , Lam CW . NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma. Cell Mol Immunol 2013; 10(4): 317–329

[160] Kutikhin AG . Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Hum Immunol 2011; 72(10): 955–968

[161] Li X , Liu S , Jin L , Ma Y , Liu T . NOD2 inhibits the proliferation of esophageal adenocarcinoma cells through autophagy. J Cancer Res Clin Oncol 2023; 149(2): 639–652

[162] Grant AV , Alter A , Huong NT , Orlova M , Van Thuc N , Ba NN , Thai VH , Abel L , Schurr E , Alcais A . Crohn’s disease susceptibility genes are associated with leprosy in the Vietnamese population. J Infect Dis 2012; 206(11): 1763–1767

[163] Pusceddu MM , Barboza M , Keogh CE , Schneider M , Stokes P , Sladek JA , Kim HJD , Torres-Fuentes C , Goldfild LR , Gillis SE , Brust-Mascher I , Rabasa G , Wong KA , Lebrilla C , Byndloss MX , Maisonneuve C , Bäumler AJ , Philpott DJ , Ferrero RL , Barrett KE , Reardon C , Gareau MG . Nod-like receptors are critical for gut–brain axis signalling in mice. J Physiol 2019; 597(24): 5777–5797

[164] Bialecka M , Kurzawski M , Klodowska-Duda G , Opala G , Juzwiak S , Kurzawski G , Tan EK , Drozdzik M . CARD15 variants in patients with sporadic Parkinson’s disease. Neurosci Res 2007; 57(3): 473–476

[165] Appenzeller S , Thier S , Papengut F , Klein C , Hagenah J , Kasten M , Berg D , Srulijes K , Gasser T , Schreiber S , Deuschl G , Kuhlenbäumer G . No association between NOD2 variants and Parkinson’s disease. Mov Disord 2012; 27(9): 1191–1192

[166] Wilson DM , Cookson MR , Van Den Bosch L , Zetterberg H , Holtzman DM , Dewachter I . Hallmarks of neurodegenerative diseases. Cell 2023; 186(4): 693–714

[167] De Luna N , Carbayo Á , Dols-Icardo O , Turon-Sans J , Reyes-Leiva D , Illan-Gala I , Jericó I , Pagola-Lorz I , Lleixà C , Querol L , Rubio-Guerra S , Alcolea D , Fortea J , Lleó A , Cortés-Vicente E , Rojas-Garcia R . Neuroinflammation-related proteins NOD2 and Spp1 are abnormally upregulated in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 2023; 10(2): e200072

[168] Fani Maleki A , Cisbani G , Laflamme N , Prefontaine P , Plante MM , Baillargeon J , Rangachari M , Gosselin J , Rivest S . Selective immunomodulatory and neuroprotective effects of a NOD2 receptor agonist on mouse models of multiple sclerosis. Neurotherapeutics 2021; 18(2): 889–904

[169] Shaw PJ , Barr MJ , Lukens JR , McGargill MA , Chi H , Mak TW , Kanneganti TD . Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity 2011; 34(1): 75–84

[170] Ozbayer C , Kurt H , Kebapci MN , Gunes HV , Colak E , Degirmenci I . Effects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance. J Clin Pharm Ther 2017; 42(1): 98–102

[171] Cuda C , Badawi A , Karmali M , El-Sohemy A . Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes. Genes Nutr 2012; 7(3): 427–435

[172] Du P , Fan B , Han H , Zhen J , Shang J , Wang X , Li X , Shi W , Tang W , Bao C , Wang Z , Zhang Y , Zhang B , Wei X , Yi F . NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int 2013; 84(2): 265–276

[173] Denou E , Lolmède K , Garidou L , Pomie C , Chabo C , Lau TC , Fullerton MD , Nigro G , Zakaroff-Girard A , Luche E , Garret C , Serino M , Amar J , Courtney M , Cavallari JF , Henriksbo BD , Barra NG , Foley KP , McPhee JB , Duggan BM , O'Neill HM , Lee AJ , Sansonetti P , Ashkar AA , Khan WI , Surette MG , Bouloumié A , Steinberg GR , Burcelin R , Schertzer JD . Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Mol Med 2015; 7(3): 259–274

[174] Cavallari JF , Fullerton MD , Duggan BM , Foley KP , Denou E , Smith BK , Desjardins EM , Henriksbo BD , Kim KJ , Tuinema BR , Stearns JC , Prescott D , Rosenstiel P , Coombes BK , Steinberg GR , Schertzer JD. . Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4.. Cell Metab 2017; 25(5): 1063–1074

[175] Williams L , Alshehri A , Robichaud B , Cudmore A , Gagnon J . The role of the bacterial muramyl dipeptide in the regulation of GLP-1 and glycemia. Int J Mol Sci 2020; 21(15): 5252

[176] Vlacil AK , Schuett J , Ruppert V , Soufi M , Oberoi R , Shahin K , Wächter C , Tschernig T , Lei Y , Liu F , Tietge UJF , Schieffer B , Schuett H , Grote K . Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis. Basic Res Cardiol 2020; 115(4): 47

[177] Basu P , Das AA , Siddiqui KN , Mondal PC , Bandyopadhyay A . Novel role of peptidoglycan recognition protein 2 in activating NOD2–NFkappaB inflammatory axis in coronary artery disease. Atherosclerosis 2024; 389: 117436

[178] Omaru N , Watanabe T , Kamata K , Minaga K , Kudo M . Activation of NOD1 and NOD2 in the development of liver injury and cancer. Front Immunol 2022; 13: 1004439

[179] Sharzehan MAK , Sito H , Islam MA , Jamal R , Tan SC . NOD2 polymorphisms and their association with colorectal cancer risk: an updated systematic review and meta-analysis. Cancers (Basel) 2025; 17(12): 1999

[180] Yun F , Wu N , Yi X , Zhang X , Feng Y , Ni Q , Gai Y , Li E , Yang Z , Zhang Q , Sai B , Kuang Y , Zhu Y . NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis. Cell Death Dis 2024; 15(10): 720

[181] Kurzawski G , Suchy J , Kladny J , Grabowska E , Mierzejewski M , Jakubowska A , Debniak T , Cybulski C , Kowalska E , Szych Z , Domagala W , Scott RJ , Lubinski J . The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 2004; 64(5): 1604–1606

[182] Liu J , He C , Xu Q , Xing C , Yuan Y . NOD2 polymorphisms associated with cancer risk: a meta-analysis. PLoS One 2014; 9(2): e89340

[183] Tian Y , Li Y , Hu Z , Wang D , Sun X , Ren C . Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis. Int J Colorectal Dis 2010; 25(2): 161–168

[184] Angeletti S , Galluzzo S , Santini D , Ruzzo A , Vincenzi B , Ferraro E , Spoto C , Lorino G , Graziano N , Calvieri A , Magnani M , Graziano F , Pantano F , Tonini G , Dicuonzo G . NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol 2009; 70(9): 729–732

[185] Hnatyszyn A , Szalata M , Stanczyk J , Cichy W , Slomski R . Association of c.802C>T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients. Exp Mol Pathol 2010; 88(3): 388–393

[186] Ferrand A , Al Nabhani Z , Tapias NS , Mas E , Hugot JP , Barreau F . NOD2 expression in intestinal epithelial cells protects toward the development of inflammation and associated carcinogenesis. Cell Mol Gastroenterol Hepatol 2019; 7(2): 357–369

[187] Udden SMN , Peng L , Gan JL , Shelton JM , Malter JS , Hooper LV , Zaki MH . NOD2 suppresses colorectal tumorigenesis via downregulation of the TLR pathways. Cell Rep 2017; 19(13): 2756–2770

[188] Wang Y , Miao Z , Qin X , Li B , Han Y . NOD2 deficiency confers a pro-tumorigenic macrophage phenotype to promote lung adenocarcinoma progression. J Cell Mol Med 2021; 25: 7545–7558

[189] Ma X , Qiu Y , Sun Y , Zhu L , Zhao Y , Li T , Lin Y , Ma D , Qin Z , Sun C , Han L . NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway. Cell Death Dis 2020; 11(3): 174

[190] Vallejos OP , Bueno SM , Kalergis AM . Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects. Trends Mol Med 2025; 31(8): 731–742

[191] DuPont AW , DuPont HL . The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8(9): 523–531

[192] Ananthakrishnan AN , Whelan K , Allegretti JR , Sokol H . Diet and microbiome-directed therapy 2.0 for IBD. Clin Gastroenterol Hepatol 2025; 23(3): 406–418

[193] Zhang J , Zhang X , Cheng X , Wang S , Lv Y , Zheng X , Wu G . Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application. Front Med (Lausanne) 2025; 12: 1620079

[194] Barragan-Carrillo R , Zengin ZB , Pal SK . Microbiome modulation for the treatment of solid neoplasms. J Clin Oncol 2025; 43(24): 2734–2738

[195] Tang LB , Peng YL , Chen J , Li JT , Zheng MM , Wu L , Lu C , Wei XW , Cai DX , Guo Z , Ren ZR , Lv SD , Deng Y , Chen ZH , Xu CR , Zhou Q . Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer. Nat Rev Clin Oncol 2025; 22(8): 546–565

[196] Wang SL , Chan TA . Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy. Cancer Cell 2025; 43(4): 641–664

[197] Simpson RC , Shanahan ER , Scolyer RA , Long GV . Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol 2023; 20(10): 697–715

[198] Griffin ME , Espinosa J , Becker JL , Luo JD , Carroll TS , Jha JK , Fanger GR , Hang HC . Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy. Science 2021; 373(6558): 1040–1046

[199] Griffin ME , Tsukidate T , Hang HC . N-Arylpyrazole NOD2 agonists promote immune checkpoint inhibitor therapy. ACS Chem Biol 2023; 18(6): 1368–1377

[200] Crawford AL , Laiteerapong N . Type 2 diabetes. Ann Intern Med 2024; 177(6): ITC81–ITC96

[201] Tousoulis D , Papageorgiou N , Androulakis E , Siasos G , Latsios G , Tentolouris K , Stefanadis C . Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol 2013; 62(8): 667–676

[202] Chatterjee S , Khunti K , Davies MJ . Type 2 diabetes. Lancet 2017; 389(10085): 2239–2251

[203] Thaiss CA , Levy M , Grosheva I , Zheng D , Soffer E , Blacher E , Braverman S , Tengeler AC , Barak O , Elazar M , Ben-Zeev R , Lehavi-Regev D , Katz MN , Pevsner-Fischer M , Gertler A , Halpern Z , Harmelin A , Aamar S , Serradas P , Grosfeld A , Shapiro H , Geiger B , Elinav E . Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science 2018; 359(6382): 1376–1383

[204] Lutter CK , Lutter R . Fetal and early childhood undernutrition, mortality, and lifelong health. Science 2012; 337(6101): 1495–1499

[205] Chen RY , Mostafa I , Hibberd MC , Das S , Mahfuz M , Naila NN , Islam MM , Huq S , Alam MA , Zaman MU , Raman AS , Webber D , Zhou C , Sundaresan V , Ahsan K , Meier MF , Barratt MJ , Ahmed T , Gordon JI . A microbiota-directed food intervention for undernourished children. N Engl J Med 2021; 384(16): 1517–1528

Rights & permissions

Higher Education Press